Peter McColgan

3.8k total citations · 1 hit paper
56 papers, 2.3k citations indexed

About

Peter McColgan is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Peter McColgan has authored 56 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Neurology, 26 papers in Cellular and Molecular Neuroscience and 16 papers in Molecular Biology. Recurrent topics in Peter McColgan's work include Genetic Neurodegenerative Diseases (25 papers), Neurological disorders and treatments (16 papers) and Advanced Neuroimaging Techniques and Applications (14 papers). Peter McColgan is often cited by papers focused on Genetic Neurodegenerative Diseases (25 papers), Neurological disorders and treatments (16 papers) and Advanced Neuroimaging Techniques and Applications (14 papers). Peter McColgan collaborates with scholars based in United Kingdom, United States and Switzerland. Peter McColgan's co-authors include Sarah J. Tabrizi, Geraint Rees, Rimona S. Weil, Angeliki Zarkali, Andrew J. Lees, Louise‐Ann Leyland, Pankaj Sharma, Paul Bentley, Adeel Razi and Pankaj Sharma and has published in prestigious journals such as Nature Communications, Nature reviews. Neuroscience and PLoS ONE.

In The Last Decade

Peter McColgan

52 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Huntington's disease: a clinical review

2017 709 citations Peter McColgan, Sarah J. Tabrizi profile →

Peers

Peter McColgan

NEURO

CMN

RNMI

Elena Salvatore Italy

Masahiro Mishina Japan

Ryder P. Gwinn United States

Ilan Ziv Israel

Ian F. Harrison United Kingdom

Wei Song China

Takeharu Kakiuchi Japan

Marina Grisoli Italy

Keiichi Oda Japan

Elena Salvatore Italy

Peter McColgan

902 ×1.0

NEURO

1.0k ×1.2

CMN

828 ×1.1

501 ×1.1

627 ×2.0

RNMI

Citations per year, relative to Peter McColgan Peter McColgan (= 1×) peers Elena Salvatore

Countries citing papers authored by Peter McColgan

Since Specialization

Citations

This map shows the geographic impact of Peter McColgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter McColgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter McColgan more than expected).

Fields of papers citing papers by Peter McColgan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter McColgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter McColgan. The network helps show where Peter McColgan may publish in the future.

Co-authorship network of co-authors of Peter McColgan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter McColgan. A scholar is included among the top collaborators of Peter McColgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter McColgan. Peter McColgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Estevez‐Fraga, Carlos, Justine Y. Hansen, Paul Zeun, et al.. (2025). Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease. Nature Communications. 16(1). 5519–5519.

Zarkali, Angeliki, Peter McColgan, Amanda Heslegrave, et al.. (2024). Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes. Brain Communications. 6(3). fcae130–fcae130. 6 indexed citations

Caron, Nicholas S., Lauren M. Byrne, Jeffrey N. Bone, et al.. (2024). Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington’s disease mice. Translational Neurodegeneration. 13(1). 50–50.

Estevez‐Fraga, Carlos, André Altmann, Christopher S. Parker, et al.. (2023). Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration. Brain. 146(11). 4532–4546. 18 indexed citations

Edwards, Luke, Peter McColgan, Saskia Helbling, et al.. (2022). Quantitative MRI maps of human neocortex explored using cell type-specific gene expression analysis. Cerebral Cortex. 33(9). 5704–5716. 6 indexed citations

McColgan, Peter, Sarah Gregory, Paul Zeun, et al.. (2022). Neurofilament light-associated connectivity in young-adult Huntington’s disease is related to neuronal genes. Brain. 145(11). 3953–3967. 7 indexed citations

Zarkali, Angeliki, Andrea I. Luppi, Emmanuel A. Stamatakis, et al.. (2022). Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease. Communications Biology. 5(1). 928–928. 18 indexed citations

Hawellek, David J., et al.. (2022). E10 Cross-sectional exploration of the clinical utility of brain age as an imaging-based marker of disease pathology in Huntington’s disease (HD) based on the tominersen phase III trial generation HD 1. A35.1–A35. 1 indexed citations

Zarkali, Angeliki, Peter McColgan, Louise‐Ann Leyland, Andrew J. Lees, & Rimona S. Weil. (2021). Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease. Movement Disorders. 36(5). 1191–1202. 36 indexed citations

10.

Zarkali, Angeliki, Peter McColgan, Louise‐Ann Leyland, et al.. (2021). Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease. Communications Biology. 4(1). 86–86. 52 indexed citations

11.

Thomas, George E., Angeliki Zarkali, Mina Ryten, et al.. (2021). Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease. Brain. 144(6). 1787–1798. 72 indexed citations

12.

Zarkali, Angeliki, Peter McColgan, Mina Ryten, et al.. (2020). Differences in network controllability and regional gene expression underlie hallucinations in Parkinson’s disease. Brain. 143(11). 3435–3448. 35 indexed citations

13.

Zarkali, Angeliki, Peter McColgan, Louise‐Ann Leyland, et al.. (2020). Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction. Neurology. 94(14). e1525–e1538. 47 indexed citations

14.

McColgan, Peter, et al.. (2020). The human motor cortex microcircuit: insights for neurodegenerative disease. Nature reviews. Neuroscience. 21(8). 401–415. 59 indexed citations

15.

Li, Xiang, Shanghong Xie, Peter McColgan, et al.. (2018). Learning Subject-Specific Directed Acyclic Graphs With Mixed Effects Structural Equation Models From Observational Data. Frontiers in Genetics. 9. 430–430. 1 indexed citations

16.

McColgan, Peter, Kiran Seunarine, Sarah Gregory, et al.. (2017). Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease. JCI Insight. 2(8). 33 indexed citations

17.

McColgan, Peter, Kiran Seunarine, Adeel Razi, et al.. (2015). Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease. Brain. 138(11). 3327–3344. 76 indexed citations

18.

McColgan, Peter, Steven F. Viegas, Sonia Gandhi, et al.. (2014). Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient. Journal of Neurology. 262(1). 228–234. 25 indexed citations

19.

Moss, Davina J. Hensman, Mark Poulter, Jon Beck, et al.. (2013). C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology. 82(4). 292–299. 137 indexed citations

20.

McColgan, Peter, Jonathan Evans, David P. Breen, et al.. (2012). Addenbrooke's Cognitive Examination‐Revised for mild cognitive impairment in Parkinson's disease. Movement Disorders. 27(9). 1173–1177. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact